Ubiquitin-like modifier activating enzyme 1 peptide fragment, which is up-regulated in newly diagnosed AML patients, may decrease and approach to the normal level in their relative intensities after complete remission. The gene discussed is UBA1; the disease is acute myeloid leukemia.